Menu
Back to Journals » OncoTargets and Therapy » Volume 12
CD40L inhibits cell growth of THP-1 cells by suppressing the PI3K/Akt pathway [Corrigendum]
Feng Z, Chen Q, Ren M, Tian Z, Gong Y. OncoTargets Ther. 2019;12:3011–3017
The author list and affiliations should be: Zhongxin Feng,1 Qi Chen,1 Mingqiang Ren,1 Zuguo Tian,1 Yuping Gong2
1Department of Hematology, Affiliated Hospital of Zunyi Medical University, Zunyi, People’s Republic of China; 2Department of Hematology, West China School of Medicine/West China Hospital, Sichuan University, Chengdu, People’s Republic of China
The corresponding author should be:
Correspondence: Qi Chen Department of Hematology, Affiliated Hospital of Zunyi Medical University, No149, Dalian Road, Guizhou, Zunyi 563003, People’s Republic of China
Tel +86 851 2860 8538
Fax +86 851 2860 8538
Email [email protected]
© 2019 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.